![Karin Jooss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karin Jooss
Directeur/Bestuurslid bij
FATE THERAPEUTICS, INC.
Vermogen: 26 590 $ op 30-06-2026
Profiel
Karin Jooss is currently an Independent Director at Fate Therapeutics, Inc. since 2019.
Former positions include Executive VP & Head-Research & Development at Nexoplex Bio, Inc. from 2021 to 2024, Head-Cancer Immunotherapeutics at Pfizer Inc. from 2009 to 2016, and Vice President-Research at Cell Genesys, Inc. from 2005 to 2009.
Education includes a doctorate from Philipps University of Marburg.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-06-2026 | 9.848 ( 0,01% ) | 26 590 $ | 30-06-2026 |
Actieve functies van Karin Jooss
| Bedrijven | Functie | Begin |
|---|---|---|
| FATE THERAPEUTICS, INC. | Directeur/Bestuurslid | 14-03-2019 |
Eerdere bekende functies van Karin Jooss
| Bedrijven | Functie | Einde |
|---|---|---|
| GRITSTONE BIO, INC. | Hoofd Techniek/Wetenschap/O&O | 31-12-2024 |
| PFIZER INC. | Corporate Officer/Principal | 01-04-2016 |
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Hoofd Techniek/Wetenschap/O&O | 01-04-2009 |
Opleiding van Karin Jooss
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
69
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Philipps University of Marburg
 Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
